Yahoo Finance Sandra Pessin of Nephros, Inc. (NASDAQ:NEPH) Just Spent US$300k On Shares
Investors who take an interest in Nephros, Inc. (NASDAQ:NEPH) should definitely note that insider Sandra Pessin recently paid US$6.00 per share to buy US$300k worth of the stock. That's a very decent purchase to our minds and it grew their holding by a solid 11%.
View our latest analysis for Nephros
Nephros Insider Transactions Over The Last Year
In fact, the recent purchase by Sandra Pessin was the biggest purchase of Nephros shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of US$6.88. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. In this case we're pleased to report that the insider purchases were made at close to current prices.
In the last twelve months Nephros insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
Nephros is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Insider Ownership of Nephros
Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 14% of Nephros shares, worth about US$8.9m, according to our data. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
So What Does This Data Suggest About Nephros Insiders?
It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Nephros insiders are expecting a bright future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Nephros. To assist with this, we've discovered 3 warning signs that you should run your eye over to get a better picture of Nephros.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.
